The future of vital sign monitoring: Testing and comparing ambulatory monitoring devices accuracy and wearability

Physiotherapy ◽  
2021 ◽  
Vol 113 ◽  
pp. e159
Author(s):  
C. Areia ◽  
S. Vollam ◽  
M. Santos ◽  
L. Young ◽  
E. King ◽  
...  
Biofeedback ◽  
2010 ◽  
Vol 38 (2) ◽  
pp. 78-82 ◽  
Author(s):  
John G. Arena

Abstract The use of surface electromyography (SEMG) has increased exponentially in the past four decades. SEMG is one of the most widespread measures employed today in psychophysiological assessment and one of three primary biofeedback modalities. This article briefly outlines three areas that the author believes are important for SEMG to address if it is to continue to flourish in the future: applications in telehealth, the use of telemetry and ambulatory monitoring, and studies on the stability or reliability of surface electromyography.


2010 ◽  
Vol 6 (3) ◽  
pp. 325-342 ◽  
Author(s):  
Ross Arena ◽  
Jonathan Myers ◽  
Marco Guazzi

1996 ◽  
Vol 17 (3) ◽  
pp. 210-216
Author(s):  
James B. Weitzman ◽  
John M. McCabe ◽  
Carlos R. Perez

1995 ◽  
Vol 3 (2) ◽  
pp. 163-177 ◽  
Author(s):  
W. Jack Rejeski ◽  
Karen M. Neal ◽  
Martine E. Wurst ◽  
Peter H. Brubaker ◽  
Walter H. Ettinger

An elderly patient population was used to investigate whether an acute bout of aerobic exercise (AE) would reduce systolic blood pressure (SBP) to a greater extent than would a bout of weight lifting (WL). SBPs were studied in the context of a laboratory Stressor as well as during activities of daily living using ambulatory monitoring devices (AMBPs). Patients participated in a laboratory Stressor and were monitored via AMBP for 8 hr. SBPs were lower for up to 5 hr postexercise for the AE treatment only. In addition, in comparison to no-exercise control data, baseline SBP was lower for the AE group than the WL group prior to the Stressor. Subjects in the AE condition also tended to have lower SBP responses following exercise than patients in the WL group, although these differences did not reach a conventional level of statistical significance. These data provide evidence that single bouts of AE, but not WL, may lower SBP in elderly patients, even for those who have compromised function due to osteoarthritis of the knee.


Author(s):  
Ricardo A. Samson ◽  
Amber E. Beal ◽  
Margo E. Hill ◽  
Rowena L. Fortin ◽  
Sean P. Gallagher

Author(s):  
Rathnakar P Urval ◽  
Priyanka Kamath ◽  
Medha Urval ◽  
Kashvi Gupta ◽  
Ashwin Kamath

2020 ◽  
Vol 44 (11) ◽  
Author(s):  
Angela A. T. Schuurmans ◽  
Peter de Looff ◽  
Karin S. Nijhof ◽  
Catarina Rosada ◽  
Ron H. J. Scholte ◽  
...  

Abstract Wearable monitoring devices are an innovative way to measure heart rate (HR) and heart rate variability (HRV), however, there is still debate about the validity of these wearables. This study aimed to validate the accuracy and predictive value of the Empatica E4 wristband against the VU University Ambulatory Monitoring System (VU-AMS) in a clinical population of traumatized adolescents in residential care. A sample of 345 recordings of both the Empatica E4 wristband and the VU-AMS was derived from a feasibility study that included fifteen participants. They wore both devices during two experimental testing and twelve intervention sessions. We used correlations, cross-correlations, Mann-Whitney tests, difference factors, Bland-Altman plots, and Limits of Agreement to evaluate differences in outcomes between devices. Significant correlations were found between Empatica E4 and VU-AMS recordings for HR, SDNN, RMSSD, and HF recordings. There was a significant difference between the devices for all parameters but HR, although effect sizes were small for SDNN, LF, and HF. For all parameters but RMSSD, testing outcomes of the two devices led to the same conclusions regarding significance. The Empatica E4 wristband provides a new opportunity to measure HRV in an unobtrusive way. Results of this study indicate the potential of the Empatica E4 as a practical and valid tool for research on HR and HRV under non-movement conditions. While more research needs to be conducted, this study could be considered as a first step to support the use of HRV recordings provided by wearables.


2021 ◽  
Vol 17 (3) ◽  
Author(s):  
Matthew J. Reed ◽  
Rachel O'Brien ◽  
Polly L. Black ◽  
Steff Lewis ◽  
Hannah Ensor ◽  
...  

Continuous novel ambulatory monitoring may detect deterioration in Emergency Department (ED) patients more rapidly, prompting treatment and preventing adverse events. Single-centre, open-label, prospective, observational cohort study recruiting high/medium acuity (Manchester triage category 2 and 3) participants, aged over 16 years, presenting to ED. Participants were fitted with a novel wearable monitoring device alongside standard clinical care (wired monitoring and/or manual clinical staff vital sign recording) and observed for up to 4 hours in the ED. Primary outcome was time to detection of deterioration. Two-hundred and fifty (250) patients were enrolled. In 82 patients (32.8%) with standard monitoring (wired monitoring and/or manual clinical staff vital sign recording), deterioration in at least one vital sign was noted during their four-hour ED stay. Overall, the novel device detected deterioration a median of 34 minutes earlier than wired monitoring (Q1, Q3 67,194; n=73, mean difference 39.48, p<0.0001). The novel device detected deterioration a median of 24 minutes (Q1, Q3 2,43; n=42) earlier than wired monitoring and 65 minutes (Q1, Q3 28,114; n=31) earlier than manual vital signs. Deterioration in physiology was common in ED patients. ED staff spent a significant amount of time performing observations and responding to alarms, with many not escalated. The novel device detected deterioration significantly earlier than standard care.


Sign in / Sign up

Export Citation Format

Share Document